2016•Journal of Thoracic OncologyOpen access

Sequential Therapy with Crizotinib and Alectinib in ALK -Rearranged Non–Small Cell Lung Cancer—A Multicenter Retrospective Study

Kentaro Ito, Osamu Hataji, Hiroyasu Kobayashi, Atsushi Fujiwara, Masamichi Yoshida, Corina N. D’Alessandro‐Gabazza, Hidetoshi Itani, Motoaki Tanigawa, Takuya Ikeda, Kentaro Fujiwara, Hajime Fujimoto, Tetsu Kobayashi, Esteban C. Gabazza, Osamu Taguchi, Nobuyuki Yamamoto

Open full text 57 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 57 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Crizotinib, Alectinib, Medicine, Anaplastic lymphoma kinase, ALK inhibitor, Lung cancer, Internal medicine, Oncology